Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases
- PMID: 20190185
- DOI: 10.1093/jnci/djq008
Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases
Abstract
Background: The prognostic relevance of isolated tumor cells and micrometastases in lymph nodes from patients with breast cancer has become a major issue since the introduction of the sentinel lymph node procedure. We conducted a systematic review of this issue.
Methods: Studies published from January 1, 1977, until August 11, 2008, were identified by use of MEDLINE, EMBASE, and the Cochrane Library. A total of 58 studies (total number of patients = 297,533) were included and divided into three categories according to the method for pathological assessment of the lymph nodes: cohort studies with single-section pathological examination of axillary lymph nodes (n = 285,638 patients), occult metastases studies with retrospective examination of negative lymph nodes by step sectioning and/or immunohistochemistry (n = 7740 patients), and sentinel lymph node biopsy studies with intensified work-up of the sentinel but not of the nonsentinel lymph nodes (n = 4155 patients). We used random-effects meta-analyses to calculate pooled estimates of the relative risks (RRs) of 5- and 10-year disease recurrence and death and the multivariably corrected pooled hazard ratio (HR) of overall survival of the cohort studies.
Results: In the cohort studies, the presence (vs the absence) of metastases of 2 mm or less in diameter in axillary lymph nodes was associated with poorer overall survival (pooled HR of death = 1.44, 95% confidence interval [CI] = 1.29 to 1.62). In the occult metastases studies, the presence (vs the absence) of occult metastases was associated with poorer 5-year disease-free survival (pooled RR = 1.55, 95% CI = 1.32 to 1.82) and overall survival (pooled RR = 1.45, 95% CI = 1.11 to 1.88), although these endpoints were not consistently assessed in multivariable analyses. Sentinel lymph node biopsy studies were limited by small patient groups and short follow-up.
Conclusion: The presence (vs the absence) of metastases of 2 mm or less in diameter in axillary lymph nodes detected on single-section examination was associated with poorer disease-free and overall survival.
Similar articles
-
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.Health Technol Assess. 2011 Jan;15(4):iii-iv, 1-134. doi: 10.3310/hta15040. Health Technol Assess. 2011. PMID: 21276372 Free PMC article.
-
Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node.J Natl Cancer Inst. 2008 Nov 19;100(22):1574-80. doi: 10.1093/jnci/djn343. Epub 2008 Nov 11. J Natl Cancer Inst. 2008. PMID: 19001602 Free PMC article.
-
Axillary treatment for operable primary breast cancer.Cochrane Database Syst Rev. 2017 Jan 4;1(1):CD004561. doi: 10.1002/14651858.CD004561.pub3. Cochrane Database Syst Rev. 2017. PMID: 28052186 Free PMC article.
-
Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.JAMA Oncol. 2023 Nov 1;9(11):1557-1564. doi: 10.1001/jamaoncol.2023.3759. JAMA Oncol. 2023. PMID: 37733364 Free PMC article.
-
Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system.Int J Surg. 2016 Oct;34:73-80. doi: 10.1016/j.ijsu.2016.08.022. Epub 2016 Aug 22. Int J Surg. 2016. PMID: 27562691
Cited by
-
Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer.J Urol. 2013 Apr;189(4):1314-8. doi: 10.1016/j.juro.2012.10.027. Epub 2012 Oct 22. J Urol. 2013. PMID: 23085057 Free PMC article.
-
The Transcription Factor SOX18 Inhibitor Small Molecule 4 Is a Potential Treatment of Cancer-Induced Lymphatic Metastasis and Lymphangiosarcoma.Cancer Rep (Hoboken). 2025 Jan;8(1):e70110. doi: 10.1002/cnr2.70110. Cancer Rep (Hoboken). 2025. PMID: 39791369 Free PMC article.
-
Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort☆.ESMO Open. 2021 Jun;6(3):100151. doi: 10.1016/j.esmoop.2021.100151. Epub 2021 May 10. ESMO Open. 2021. PMID: 33984674 Free PMC article.
-
Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma.Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1107-15. doi: 10.1245/s10434-015-4723-9. Epub 2015 Jul 16. Ann Surg Oncol. 2015. PMID: 26178761 Free PMC article.
-
Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis.Sci Rep. 2016 May 23;6:26286. doi: 10.1038/srep26286. Sci Rep. 2016. PMID: 27212078 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical